References
- Colpak AI, Erdener SE, Ozgen B, Anlar B, Kansu T. Neuro–ophthalmology of subacute sclerosing panencephalitis: two cases and a review of the literature. Curr Opin Ophthalmol. 2012;23(6):466–71. doi:10.1097/ICU.0b013e328358b196. PMID:23047165
- Yalaz K, Anlar B, Renda Y, Aysun S, Topcu M, Ozdirim E. Subacute sclerosing panencephalitis in Turkey: epidemiological features. J Trop Pediatr. 1988;34:301–5. doi:10.1093/tropej/34.6.301. PMID:3221414
- Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis. 2001;184(7):817–26. doi:10.1086/323346. PMID:11528592
- Carson MM, Spady DW, Beeler JA, Krezolek MP, Audet S, Pabst HF. Follow– up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age. Vaccine. 2005;23(25):3247–55. doi:10.1016/j.vaccine.2005.01.092. PMID:15837229
- Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM. Humoral and cell–mediated immune responses to an early 2–dose measles vaccination regimen in the United States. J Infect Dis. 2004;190(1):83–90. doi:10.1086/421032. PMID:15195246